Skip to content
Saturday, February 28, 2026
Canada's Leading Online Business Magazine
X-twitter
Search
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
×
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
×
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
Home
CBJ Newsmakers
35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
CBJ Newsmakers
Recommended
Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program
Cognitrex Inc. Announces Market Entry of Enterprise LearningOS Platform Led by Founder Hana Dhanji
Bombardier to Provide Six Multi-role Aircraft to Support the Royal Canadian Air Force
